Skip to main content
logo
Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
2.050
-0.110 (-5.09%)
Aug 20, 2026, 11:38 AM EDT - Market open

Palisade Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.5--0.25--
Revenue Growth
------
Gross Profit
0.5--0.25--
Selling, General & Admin
14.497.865.86.28.769.31
Research & Development
21.3610.199.066.896.552.43
Operating Expenses
35.8518.0614.8613.115.3111.74
Operating Income
-35.35-18.06-14.86-12.85-15.31-11.74
Interest Expense
-0.01-0.01-0.01-0.02-0.01-3.08
Interest & Investment Income
---0.70.2-
Other Non Operating Income (Expenses)
3.421.290.430.091.2718.04
EBT Excluding Unusual Items
-31.94-16.78-14.44-12.08-13.853.22
Merger & Restructuring Charges
----0.23-0.41-
Other Unusual Items
-----0.28
Pretax Income
-31.94-16.78-14.44-12.3-14.26-26.62
Net Income
-31.94-16.78-14.44-12.3-14.26-26.62
Preferred Dividends & Other Adjustments
---0.020.29-
Net Income to Common
-31.94-16.78-14.44-12.32-14.55-26.62
Net Income Growth
------
Shares Outstanding (Basic)
159561000
Shares Outstanding (Diluted)
159561000
Shares Change
4683.09%3830.18%210.62%677.03%370.85%-
EPS (Basic)
-0.20-0.30-10.19-27.01-247.89-2144.20
EPS (Diluted)
-0.20-0.30-10.19-27.01-247.95-2546.13
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18.19-10.85-12.19-11.14-13.37-14.77
Free Cash Flow Per Share
-0.12-0.20-8.61-24.42-227.82-1185.25
Gross Margin
100.00%--100.00%--
Operating Margin
-7069.80%---5138.00%--
Profit Margin
-6388.20%---4926.40%--
Free Cash Flow Margin
-3638.00%---4454.80%--
EBITDA
-35.35-18.05-14.86-12.84-15.31-11.74
D&A For EBITDA
000000
EBIT
-35.35-18.06-14.86-12.85-15.31-11.74
SEC Filings: 10-K · 10-Q